Aim: Interleukin-17A (IL-17A) plays an essential role in tissue inflammation by inducing proinflammatory cytokine and chemokine production and is related to innate immune reactions. IL-17A also contributes to neuroinflammation, neuropathic pain, and mechanical hypersensitivity after peripheral nerve injury in rodents. To clarify the contribution of IL-17A to pain-related phenotypes in humans, we investigated the association between pain-related phenotypes and the rs2275913 single-nucleotide polymorphism (SNP) of the IL-17A gene, which has been reported to be associated with rheumatoid arthritis, ulcerative colitis, and some cancers.
| INTRODUCTION
Orthognathic surgery has been reported to induce the highest pain intensities among surgeries that cause postoperative pain. 1 In orthognathic surgery, postoperative pain is related to both somatic and neuropathic pathophysiology. Proinflammatory cytokines are associated with somatic pain. 2 Furthermore, neuropathic pain alters the expression of cytokines and cytokine receptors. 3 Thus, inflammatory systems likely engage severe postoperative pain through both somatic and neuropathic components. To control severe postoperative pain after surgery, such as orthognathic surgery, pain-related inflammatory mechanisms need to be clarified. reactions, such as autoimmune disease, protection from microbial infection, and allergic reactions. 4 Furthermore, IL-17A has been reported to contribute to neuroinflammation, neuropathic pain, and mechanical hypersensitivity after peripheral nerve injury in rodents, [5] [6] [7] but unknown is whether such findings translate to humans.
Interleukin-17A (IL-
The IL-17A gene encodes IL-17A. The rs2275913 single-nucleotide polymorphism (SNP) is located in the 2KB upstream region of the IL-17A gene on chromosome 6p12. The rs2275913 SNP is located in the promoter region of the IL-17A gene, and the A allele of rs2275913 is associated with higher promoter activity of the IL-17A
gene. 8 The AA genotype of the rs2275913 SNP of the IL-17A gene is reportedly associated with a higher risk of asthma, bronchiolitis, 9 ulcerative colitis, 10 digestive cancer, 11 gastric cancer, [11] [12] [13] and cervical cancer. 13 Other studies reported that the rs2275913 SNP had no association with pediatric systemic lupus erythematosus disease activity 14 or cervical cancer 15 and had opposite effects on rheumatoid arthritis, 16 post-bronchiolitis asthma at 11-13 years of age 17 and colorectal cancer. 13 Overall, the AA genotype of the rs2275913 SNP appears to contribute to greater inflammation, leading to autoimmune-related inflammatory diseases, including cancer. Thus, the rs2275917 SNP may reflect the autoimmune-related function of IL-17A. With regard to the function of IL-17A in preventing infection, the AA genotype of the rs2275913 SNP was shown to be associated with protection against tuberculosis but also higher disease severity, 18 hepatitis B virus (HBV) resistance, 19 and Bacillus Calmette-Gu erin (BCG) osteitis after vaccination. 20 These findings indicate that the AA genotype of the rs2275913 SNP has advantages for preventing infections, whereas this genotype overall leads to more severe inflammation. Altogether, a more severe inflammatory reaction that is associated with the AA genotype could lead to autoimmune diseases and cancer and prevent infection, indicating the fragile balance between immunity and inflammation through IL-17A. 
| Anesthesia and surgery
General anesthesia was induced with a target-controlled infusion (TCI) of propofol using a TCI pump (TE-371, Terumo, Tokyo, Japan).
Vecuronium, 0.1 mg/kg, was administered to facilitate nasotracheal intubation. After the induction of anesthesia, 10 mL of venous blood was sampled for the preparation of DNA specimens. General anesthesia was maintained with propofol at a target blood concentration of 4-6 lg/mL. Vecuronium was administered at a rate of 0.08 mg/kg/h. 
| Genotyping
Genomic DNA was extracted from whole-blood samples using standard procedures. The extracted DNA was dissolved in TE buffer (10 mmol/L Tris-HCl and 1 mmol/L EDTA, pH 8.0). The DNA concentration was adjusted to 100 ng/lL for whole-genome genotyping using a NanoDrop ND-1000 Spectrophotometer (NanoDrop Technologies, Wilmington, DE, USA). Genotype data of the rs2275913 SNP were obtained from the results of whole-genome genotyping, which was performed using HumanOmniExpressExome-8 BeadChips and Infinium assay II with an iScan system (Illumina, San Diego, CA, USA) according to the manufacturer's instructions, as described in detail in a previous study. 23 The genotyping results for the rs2275913 SNP were qualified by a data-cleaning process using
GenomeStudio with the Genotyping v3.3.7 module (Illumina). In the data-cleaning process, markers with a genotype call frequency of less than 0.95, "Cluster sep" (ie, an index of genotype cluster separation)
of less than 0.1, or P values (df = 1) less than 0.001 in the HardyWeinberg equilibrium tests were excluded from the subsequent association study. Although multiple factors other than the genotypes of the screened SNPs (eg, age and sex) may also affect fentanyl analgesia, thus suggesting the use of multivariate covariate analyses, the nonparametric distributions of most of our data precluded the application of such parametric techniques. The effects of sex and age on painrelated phenotypes were evaluated using nonparametric analyses in a previous study. 24 According to most previous reports of the rs2275913 SNP, a recessive model led to significant differences. | 69 the present nonparametric data was higher than the estimated size that possesses statistical power (1 minus type II error probability)
| Statistical analysis
of 90% for Cohen's conventional "medium" effect size of 0.3.
Power analyses were performed using G*Power v.3.0.9.2.
25
To explore the association between the rs2275913 SNP and pain-related phenotypes, the Mann-Whitney U test was performed.
For this analysis, pain-related phenotypes and genotype data for the rs2275913 SNP were incorporated as dependent and independent variables, respectively. Values of P < .05 were considered statistically significant. The box and whisker plots were graphed using GraphPad 3 | RESULTS
| Patient characteristics
A total of 354 Japanese patients were included in the analysis. The patients' demographic and clinical data are shown in Table 1 . A previous study of this same group of patients reported that sex was not significantly associated with the latency to pain perception before fentanyl administration in the cold pressor-induced pain test (PPLpre) or VAS 3 or 24 hours after surgery. The analgesic effect of fentanyl in the cold pressor-induced pain test (PPLpost-PPLpre) was significantly greater in males than in females (P = .009), and total perioperative analgesic use was significantly less in males than in females (P < .001; Mann-Whitney U test). 24 The study also reported that age was not significantly associated with any of the clinical endpoints (Spearman's rank correlation test), and PPLpost-PPLpre was not associated with VAS pain scores at 24 hours. 24 The minor A allele frequency of the rs2275913 SNP of the IL-17A gene was 39%
in the Japanese population in this study.
| Statistical analysis
In this study, Pearson's chi-squared test or classic multidimensional scaling revealed no significant difference in sex or age among the subjects who carried different genotypes of the rs2275913 SNP (P > .05), indicating that the clinical outcomes among genotypes were not influenced by sex or age. The clinically measured endpoints that were related to pain sensitivity (ie, PPLpre and PPLpost-PPLpre) and analgesic effects (ie, total operative analgesic use and VAS pain scores at 24 hours) were unrelated to the rs2275913 SNP and were not normally distributed. Therefore, nonparametric analysis was used to detect possible associations between the rs2275913 SNP and clinical endpoints that were related to opioid requirements and VAS pain scores.
| Effects of rs2275913 SNP on pain-related phenotypes
The Mann-Whitney U test revealed a significant difference in total perioperative analgesic use between the AA group and AG + GG group of the rs2275913 SNP for males and females combined and for females alone (converted to fentanyl doses; males and females combined: P = .00901; females: P = .0443; Table 2 ), whereas the difference was not significant for males only (males: P = .111). As represented by box and whisker plots in Figure 1A , the AA group required more analgesics than the AG + GG group. Even when the samples were divided into 3 groups, the AA group required more analgesics than the AG and GG groups, based on median opioid requirements. Median opioid requirements linearly increased as the copy number of the minor A allele of the SNP increased ( Figure 1B ).
To clearly demonstrate linearity, we adopted linear regression analy- With regard to sex differences, the AA group required more analgesics than the AG + GG group for both males and females, although only females exhibited a statistically significant difference ( Figure 1C, D) . Median opioid requirements incrementally increased as the copy number of the A allele increased for both males and females ( Figure 1C, D) . The linear regression analysis that utilized an additive genetic model indicated that both males and females exhibited a trend toward a positive correlation between opioid requirements and the copy number of the A allele of the SNP, although this correlation was not statistically significant (males: P = .0939; females: P = .0503). Altogether, both males and females presented similar trends as males and females combined in the association between the A allele and opioid requirements.
The rs2275913 SNP was not significantly associated with PPLpre (males and females combined: P = .799; males: P = .251; females: P = .378; Table 2 ), PPLpost-PPLpre (males and females combined: P = .909; males: P = .296; females: P = .656; Table 2 ), or VAS pain scores at 24 hours (males and females combined: P = .993; males: P = .508; females: P = .691; Table 2 ).
| DISCUSSION
It has been reported that pain has an impact on reward/motivation circuits in humans. 26 Together with the fact that the activation of the reward system enhances innate and adaptive immunity in humans, 27 pain relates to immune system through reward system in humans. The proinflammatory cytokine IL-17A has been shown to be related to hypersensitivity after peripheral nerve injury, PPL, latency to pain perception; VAS, visual analog scale. *P < .05, **P < .01.
F I G U R E 1
Associations between genotypes of the rs2275913 SNP and total perioperative analgesic use after cosmetic orthognathic surgery (n = 354). The data are expressed as box and whisker plots. The upper and lower ends of the boxes represent the 75th and 25th percentiles, respectively. Whiskers represent the highest and lowest values. The median is depicted by a horizontal solid line in the box. Outliers and extreme values are shown as circles and triangles, respectively. ns, not significant. *P < .05, **P < .01. A, The samples were divided into 2 groups (AA and AG + GG); B, The samples were divided into 3 groups (AA, AG, and GG); C, The male samples were divided into 3 groups; D, The female samples were divided into 3 groups OHKA ET AL.
| 71 neuropathic pain, and neuroinflammation in rodents, [5] [6] [7] With regard to the action of IL-17A on the opioid system, morphine was shown to inhibit early IL-17A induction after pathogenic infection, leading to a lower protective response and sustained inflammation in mice. [28] [29] [30] [31] Morphine was also shown to reduce IL-17A secretion from cultured CD4+ T cells from peripheral blood samples from morphine-and cannabinoid-addicted humans. 32 On the other hand, morphine exposure for 3 months increased the functional activity of Th17 cells in rhesus macaques. 33 Furthermore, mechanical allodynia and thermal hyperalgesia in rats after exposure to the l-opioid receptor agonist remifentanil were accompanied by an increase in IL-17A/IL-17RA expression. 34 Based on these reports, one possibility is that opioids induce steady-state IL-17A expression in healthy humans, whereas decrease IL-17A induction after infection or reduce IL-17A secretion in morphine-and cannabinoidaddicted humans. However, no studies have investigated the ways in which opioids affect IL-17A.
The total perioperative analgesic use differed significantly between the AA group and AG + GG group of the rs2275913 SNP for males and females combined and for females alone (converted to fentanyl doses; males and females combined: P = .00901; females: P = .0443; Table 2 ), whereas the difference was not significant for males alone (males: P = .111). Fukuda et al found that total perioperative analgesic use was significantly less in males than in females of the same samples (P < .001; Mann-Whitney U test). 24 Based on these previous findings, the increase in opioid requirements in females in the present study may be at least partially attributable to sex-dependent opioid requirements. Consequently, although males did not present a significant difference, males and females combined presented the most significant difference, and the amount of opioid requirements increased incrementally as the copy number of the A allele increased for males and females com- 
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